102 related articles for article (PubMed ID: 26524535)
1. Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis.
Kumar V; Mondal G; Dutta R; Mahato RI
Biomaterials; 2016 Jan; 76():144-56. PubMed ID: 26524535
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potential of OMe-PS-miR-29b1 for Treating Liver Fibrosis.
Kumar V; Kumar V; Luo J; Mahato RI
Mol Ther; 2018 Dec; 26(12):2798-2811. PubMed ID: 30287074
[TBL] [Abstract][Full Text] [Related]
3. The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis.
Kumar V; Dong Y; Kumar V; Almawash S; Mahato RI
Theranostics; 2019; 9(25):7537-7555. PubMed ID: 31695785
[No Abstract] [Full Text] [Related]
4. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer.
Kumar V; Mondal G; Slavik P; Rachagani S; Batra SK; Mahato RI
Mol Pharm; 2015 Apr; 12(4):1289-98. PubMed ID: 25679326
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice.
Dutta R; Kumar V; Peng Y; Evande RE; Grem JL; Mahato RI
Pharm Res; 2017 Mar; 34(3):564-578. PubMed ID: 27995525
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis.
Kumar V; Mundra V; Mahato RI
Pharm Res; 2014 May; 31(5):1158-69. PubMed ID: 24249038
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice.
Kumar V; Mundra V; Peng Y; Wang Y; Tan C; Mahato RI
Theranostics; 2018; 8(15):4033-4049. PubMed ID: 30128034
[No Abstract] [Full Text] [Related]
8. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling.
Hyun J; Jung Y
World J Gastroenterol; 2016 Aug; 22(29):6652-62. PubMed ID: 27547008
[TBL] [Abstract][Full Text] [Related]
12. Anti-miR-96 and Hh pathway inhibitor MDB5 synergistically ameliorate alcohol-associated liver injury in mice.
Kumar V; Sethi B; Staller DW; Xin X; Ma J; Dong Y; Talmon GA; Mahato RI
Biomaterials; 2023 Apr; 295():122049. PubMed ID: 36827892
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy.
Ji D; Wang Q; Zhao Q; Tong H; Yu M; Wang M; Lu T; Jiang C
J Nanobiotechnology; 2020 Jun; 18(1):86. PubMed ID: 32513194
[TBL] [Abstract][Full Text] [Related]
14. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
Yoshida S; Ikenaga N; Liu SB; Peng ZW; Chung J; Sverdlov DY; Miyamoto M; Kim YO; Ogawa S; Arch RH; Schuppan D; Popov Y
Gastroenterology; 2014 Dec; 147(6):1378-92. PubMed ID: 25173753
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling.
Pratap A; Singh S; Mundra V; Yang N; Panakanti R; Eason JD; Mahato RI
J Drug Target; 2012 Nov; 20(9):770-82. PubMed ID: 22994359
[TBL] [Abstract][Full Text] [Related]
16. Hedgehog signaling regulates the repair response in mouse liver damaged by irradiation.
Wang S; Hyun J; Youn B; Jung Y
Radiat Res; 2013 Jan; 179(1):69-75. PubMed ID: 23181588
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
Ogawa T; Enomoto M; Fujii H; Sekiya Y; Yoshizato K; Ikeda K; Kawada N
Gut; 2012 Nov; 61(11):1600-9. PubMed ID: 22267590
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑200a suppresses epithelial‑to‑mesenchymal transition in rat hepatic stellate cells via GLI family zinc finger 2.
Yu F; Zheng Y; Hong W; Chen B; Dong P; Zheng J
Mol Med Rep; 2015 Dec; 12(6):8121-8. PubMed ID: 26499180
[TBL] [Abstract][Full Text] [Related]
19. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
20. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
